Aurelia Bioscience Ltd - Company Review
Aurelia Bioscience Ltd - Company ReviewSummary
Aurelia Bioscience Ltd (Aurelia) is a contract research organization that offers biochemical compound screening solutions. The organization offers drug discovery and instrument and reagent development services. It also provides high throughput screening, cell-based screening, phenotypic screening, biochemical screening and cell culture services. The organization provides label-free screening, FLIPR screening, FMAT screening, high content screening technologies for its projects. It undertakes research in the areas including inflammatory disease, respiratory disease, oncology, CNS-pain, rare disorders, diabetes, and others. Aurelia is headquartered in Nottingham, the UK.
This comprehensive company report of Aurelia Bioscience Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.